Skip to main content
Equibles

PROFUND ADVISORS LLC

Position in CMPX — Compass Therapeutics, Inc.

CIK 1129919 BETHESDA, MD
Back to CMPX Full portfolio

Position in CMPX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$208,507
-$255,325 QoQ
Shares Held
95,209
+8.6% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CMPX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $165,155,882 across 170 Biotechnology names. CMPX ranks #152 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 23,398 $11,622,488
2 REGN
Regeneron Pharmaceuticals, Inc.
 10,444 $6,512,251
3 ALNY
Alnylam Pharmaceuticals, Inc.
 13,814 $4,158,428
4 MRNA
Moderna, Inc.
 33,142 $2,320,934
5
17,163 $2,278,044
6 CYTK
Cytokinetics Inc
 25,572 $2,178,478
7 TWST
Twist Bioscience Corp
 21,095 $2,170,253
8 KRYS
Krystal Biotech, Inc.
 5,770 $2,144,535

All Filings in CMPX

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $208,507 95,209
2026-03-31 $463,832 87,681
2025-12-31 $307,411 57,246
2025-09-30 $57,638 16,468